BindingDB logo
myBDB logout

BDBM50045802 CHEMBL99252::{[2-(Adamantan-2-yloxycarbonylamino)-2-methyl-3-naphthalen-2-yl-propionyl]-phenethyl-amino}-acetic acid

SMILES: CC(Cc1ccc2ccccc2c1)(NC(=O)OC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2)C(=O)N(CCc1ccccc1)CC(O)=O

InChI Key: InChIKey=BCUOSLLHFNEMGW-YYDQDCEFSA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50045802   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Cholecystokinin A receptor


(Cavia porcellus)
BDBM50045802
PNG
(CHEMBL99252 | {[2-(Adamantan-2-yloxycarbonylamino)...)
Show SMILES CC(Cc1ccc2ccccc2c1)(NC(=O)OC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2)C(=O)N(CCc1ccccc1)CC(O)=O |wU:22.24,20.28,18.20,wD:24.25,TLB:16:17:19:22.26.21,THB:23:24:19:22.26.21,23:22:19:17.24.25,(14.77,-13.49,;13.46,-14.28,;12.13,-15.05,;12.13,-16.6,;13.47,-17.34,;13.49,-18.89,;12.15,-19.67,;12.16,-21.2,;10.84,-21.99,;9.49,-21.22,;9.49,-19.68,;10.82,-18.91,;10.8,-17.37,;11.96,-13.86,;10.62,-13.09,;9.52,-14.18,;10.22,-11.6,;8.74,-11.2,;6.99,-11.22,;5.92,-12.25,;4.63,-11.6,;4.09,-10.2,;5.19,-9.14,;6.83,-9,;7.41,-10.41,;6.25,-11.5,;6.43,-9.91,;14.8,-15.03,;14.77,-16.57,;16.33,-15.03,;17.1,-13.7,;18.65,-13.7,;19.42,-12.36,;18.63,-11.04,;19.4,-9.7,;20.94,-9.7,;21.73,-11.04,;20.96,-12.37,;17.11,-16.36,;18.65,-16.36,;19.42,-17.7,;19.42,-15.03,)|
Show InChI InChI=1S/C35H40N2O5/c1-35(21-24-11-12-27-9-5-6-10-28(27)16-24,33(40)37(22-31(38)39)14-13-23-7-3-2-4-8-23)36-34(41)42-32-29-17-25-15-26(19-29)20-30(32)18-25/h2-12,16,25-26,29-30,32H,13-15,17-22H2,1H3,(H,36,41)(H,38,39)/t25-,26+,29-,30+,32?,35?
PDB
MMDB

Reactome pathway

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
70n/an/an/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Tested for inhibition of [3H]-pCCK-8 specific binding to cholecystokinin type A receptor in guinea pig pancreatic membranes


J Med Chem 36: 2868-77 (1993)


BindingDB Entry DOI: 10.7270/Q2MG7NK5
More data for this
Ligand-Target Pair
Cholecystokinin receptor


(Homo sapiens (Human))
BDBM50045802
PNG
(CHEMBL99252 | {[2-(Adamantan-2-yloxycarbonylamino)...)
Show SMILES CC(Cc1ccc2ccccc2c1)(NC(=O)OC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2)C(=O)N(CCc1ccccc1)CC(O)=O |wU:22.24,20.28,18.20,wD:24.25,TLB:16:17:19:22.26.21,THB:23:24:19:22.26.21,23:22:19:17.24.25,(14.77,-13.49,;13.46,-14.28,;12.13,-15.05,;12.13,-16.6,;13.47,-17.34,;13.49,-18.89,;12.15,-19.67,;12.16,-21.2,;10.84,-21.99,;9.49,-21.22,;9.49,-19.68,;10.82,-18.91,;10.8,-17.37,;11.96,-13.86,;10.62,-13.09,;9.52,-14.18,;10.22,-11.6,;8.74,-11.2,;6.99,-11.22,;5.92,-12.25,;4.63,-11.6,;4.09,-10.2,;5.19,-9.14,;6.83,-9,;7.41,-10.41,;6.25,-11.5,;6.43,-9.91,;14.8,-15.03,;14.77,-16.57,;16.33,-15.03,;17.1,-13.7,;18.65,-13.7,;19.42,-12.36,;18.63,-11.04,;19.4,-9.7,;20.94,-9.7,;21.73,-11.04,;20.96,-12.37,;17.11,-16.36,;18.65,-16.36,;19.42,-17.7,;19.42,-15.03,)|
Show InChI InChI=1S/C35H40N2O5/c1-35(21-24-11-12-27-9-5-6-10-28(27)16-24,33(40)37(22-31(38)39)14-13-23-7-3-2-4-8-23)36-34(41)42-32-29-17-25-15-26(19-29)20-30(32)18-25/h2-12,16,25-26,29-30,32H,13-15,17-22H2,1H3,(H,36,41)(H,38,39)/t25-,26+,29-,30+,32?,35?
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
3.01E+3n/an/an/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Tested for binding affinity towards cholecystokinin type A receptor in rat pancreas by displacement of [3H]pCCK-8 radioligand


J Med Chem 36: 2868-77 (1993)


BindingDB Entry DOI: 10.7270/Q2MG7NK5
More data for this
Ligand-Target Pair